天津医药
天津醫藥
천진의약
Tianjin Medical Journal
2015年
11期
1307-1310
,共4页
刘竹枫%张碧丽%王文红%张暄%范树颖%李莉%刘艳%刘喆
劉竹楓%張碧麗%王文紅%張暄%範樹穎%李莉%劉豔%劉喆
류죽풍%장벽려%왕문홍%장훤%범수영%리리%류염%류철
巨细胞病毒%肾%生物学标记%儿童%β2微球蛋白%α1微球蛋白%N-乙酰-β-D氨基葡萄糖苷酶
巨細胞病毒%腎%生物學標記%兒童%β2微毬蛋白%α1微毬蛋白%N-乙酰-β-D氨基葡萄糖苷酶
거세포병독%신%생물학표기%인동%β2미구단백%α1미구단백%N-을선-β-D안기포도당감매
cytomegalovirus%kidney%biological markers%child%β2MG%α1MG%NAG
目的:探讨尿液生物学标志物在儿童巨细胞病毒(CMV)感染所致肾损伤以及治疗前后的变化。方法收集我科CMV感染的患儿50例作为患儿组,对照组选择健康体检儿童35例,患儿组在入院初检测血肌酐(Scr)、血尿素氮(BUN)、血β2微球蛋白(MG)、肝功能、血CMV-IgM,血及尿液CMV-PCR、脑干电测听(BAEP)、头CT、尿常规,尿液中的尿液转铁蛋白(TFR)、微量白蛋白(mALb)、β2MG、α1MG和N-乙酰-β-D氨基葡萄糖苷酶(NAG),合并CMV肺炎吸取痰液检测CMV-PCR。所有患儿均给予更昔洛韦治疗,5 mg/kg加入0.9%氯化钠溶液(5 mL/kg)中,静脉滴注,12 h 1次,每次滴注不少于1 h,持续14 d,复查尿液TFR、mALb、β2MG、α1MG和NAG。结果患儿组与对照组尿液mALb、TFR差异无统计学意义,患儿组尿液α1MG、NAG、β2MG高于对照组,患儿组予更昔洛韦抗病毒治疗2周后,复查尿液α1MG、NAG、β2MG治疗后较治疗前降低,而尿液mALb、TFR治疗前后差异无统计学意义。结论尿液β2MG、α1MG、NAG的联合检测对于早期发现儿童CMV肾损害有很好的提示作用。
目的:探討尿液生物學標誌物在兒童巨細胞病毒(CMV)感染所緻腎損傷以及治療前後的變化。方法收集我科CMV感染的患兒50例作為患兒組,對照組選擇健康體檢兒童35例,患兒組在入院初檢測血肌酐(Scr)、血尿素氮(BUN)、血β2微毬蛋白(MG)、肝功能、血CMV-IgM,血及尿液CMV-PCR、腦榦電測聽(BAEP)、頭CT、尿常規,尿液中的尿液轉鐵蛋白(TFR)、微量白蛋白(mALb)、β2MG、α1MG和N-乙酰-β-D氨基葡萄糖苷酶(NAG),閤併CMV肺炎吸取痰液檢測CMV-PCR。所有患兒均給予更昔洛韋治療,5 mg/kg加入0.9%氯化鈉溶液(5 mL/kg)中,靜脈滴註,12 h 1次,每次滴註不少于1 h,持續14 d,複查尿液TFR、mALb、β2MG、α1MG和NAG。結果患兒組與對照組尿液mALb、TFR差異無統計學意義,患兒組尿液α1MG、NAG、β2MG高于對照組,患兒組予更昔洛韋抗病毒治療2週後,複查尿液α1MG、NAG、β2MG治療後較治療前降低,而尿液mALb、TFR治療前後差異無統計學意義。結論尿液β2MG、α1MG、NAG的聯閤檢測對于早期髮現兒童CMV腎損害有很好的提示作用。
목적:탐토뇨액생물학표지물재인동거세포병독(CMV)감염소치신손상이급치료전후적변화。방법수집아과CMV감염적환인50례작위환인조,대조조선택건강체검인동35례,환인조재입원초검측혈기항(Scr)、혈뇨소담(BUN)、혈β2미구단백(MG)、간공능、혈CMV-IgM,혈급뇨액CMV-PCR、뇌간전측은(BAEP)、두CT、뇨상규,뇨액중적뇨액전철단백(TFR)、미량백단백(mALb)、β2MG、α1MG화N-을선-β-D안기포도당감매(NAG),합병CMV폐염흡취담액검측CMV-PCR。소유환인균급여경석락위치료,5 mg/kg가입0.9%록화납용액(5 mL/kg)중,정맥적주,12 h 1차,매차적주불소우1 h,지속14 d,복사뇨액TFR、mALb、β2MG、α1MG화NAG。결과환인조여대조조뇨액mALb、TFR차이무통계학의의,환인조뇨액α1MG、NAG、β2MG고우대조조,환인조여경석락위항병독치료2주후,복사뇨액α1MG、NAG、β2MG치료후교치료전강저,이뇨액mALb、TFR치료전후차이무통계학의의。결론뇨액β2MG、α1MG、NAG적연합검측대우조기발현인동CMV신손해유흔호적제시작용。
Objective To explore changes of urine transferrin (TFR),micro albumin (mALb),β2 microspheres protein (MG),α1MG and N-acetylβ-D amino group (NAG) in children with kidney injury induced by cytomegalovirus (CMV) infec?tion, and the outcome after treatment. Methods Fifty children with CMV infection were used as case group, and 35 chil?dren of convalescence stage of upper respiratory tract infection were used as control group. The serum levels of creatinine (Scr), blood urea nitrogen (BUN),β2MG, liver function, CMV-IgM, CMV-PCR and brainstem auditory (BAEP), head CT and urine routine test, urine TFR, mALb,β2MG,α2MG and NAG were detected. The sputum CMV-PCR was detected if childrencombined with CMV pneumonia. Ganciclovir (5mg/kg) was given to two groups, 1/12 h i.v. for 14 d. The urine TFR,mALb,β2MG, α2MG and NAG were detected again after treatment. Results There were no significant differences in the urine mALb and TFR between the two groups. The urine levels ofα1MG, NAG andβ2MG were higher in case group than those of control group. The urine levels ofα1MG, NAG andβ2MG were decreased after 2-week treatment in case group. There were no significant differences in urine mALb and TFR before and after treatment. Conclusion The combined detection ofβ2MG,α1MG and NAG can predict CMV kidney damage in children at a early stage.